Do you think RP is a valid option for patients with high-risk clinically localized PCa?

Share this article:

The role of radical prostatectomy (RP) for high-risk clinically localized prostate cancer (PCa) is controversial, with some data suggesting it may be associated with outcomes comparable to those of external beam radiotherapy (EBRT) with or without androgen deprivation therapy (ADT).

For example, a study by Boorjian et al. (Cancer 2011;117:2883-2891) comparing RP, EBRT alone, and EBRT plus ADT showed that the three approaches are associated with similar long-term cancer control for patients with high-risk PCa.

Renal & Urology News would like to know how urologists view the use of RP for high-risk prostate tumors, so please answer the following poll question.

Share this article:
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters

More in Physician Polls

Have you ever stopped accepting private insurance that reimburses poorly?

Doctors may be at a big disadvantage when negotiating payment rates with private insurers.

What do you think of the penalties assessed against drug companies accused ...

Pharmaceutical companies have paid billions of dollars to settle federal allegations of fraud and other wrongdoing in recent years.

Do doctors have a moral duty to serve as expert witnesses in ...

Thousands of medical malpractice suits are filed in courts across the U.S. each year.